Comments

BioMarin Pharmaceutical Stock Price, Quotes and Forecasts

Q: What sector and industry does BioMarin Pharmaceutical (BMRN) operate in?

BioMarin Pharmaceutical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

BMRNNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$56.22

-1.06-1.85%

At close: -

$56.22

0.000.00%

After Hours: Jun 13, 4:00 PM EDT

BioMarin Pharmaceutical (BMRN) Forecast

News Earnings BioMarin Pharmaceutical (BMRN) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

BioMarin Pharmaceutical Stock Price, Quotes and Forecasts | NASDAQ:BMRN | Benzinga

Explore BioMarin Pharmaceutical stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BMRN.

Open	$56.41
Close	$56.22
Volume / Avg.	1.62M / 1.97M
Day Range	$56.04 - $57.36
52 Wk Range	52.93 - 94.85
Market Cap	$10.73B
P/E Ratio	21.21
Dividend Yield	-
Exchange	NASDAQ
RSI	39
Short Interest	2.19%
Days to Cover	1.56

Recent News

Jim Cramer Is All Aboard Union Pacific, But Shows No Love For Orphan Drugs

Jim Cramer recommends Union Pacific but is "getting tired of the orphan drug model." Here's what the "Mad Money" host said.

Avi Kapoor

Trump's New Order Targets Drug Pricing Transparency And Medicare Cost Reduction

Trump orders multi-part executive order to lower drug prices, reduce Medicare costs. Includes guidance on Medicare drug prices, aligning payments with hospital acquisition costs, and investigating anti-competitive practices.

Vandana Singh

BioMarin Seeks Label Expansion For Palynziq After Positive Phase 3 Results In Adolescent Patients

BioMarin's Phase 3 trial shows Palynziq significantly reduces blood Phe in adolescents with PKU. The company plans a regulatory submission for label expansion.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$56.41
Close	$56.22
Volume / Avg.	1.62M / 1.97M
Day Range	$56.04 - $57.36
52 Wk Range	52.93 - 94.85
Market Cap	$10.73B
P/E Ratio	21.21
Dividend Yield	-
Exchange	NASDAQ
RSI	39
Short Interest	2.19%
Days to Cover	1.56

About Biomarin Pharmaceutical Inc.

Sector

Health Care

Industry

Biotechnology

BioMarin is a global biotechnology company focused on developing and commercializing therapies for r...

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy BioMarin Pharmaceutical (BMRN) stock?

You can purchase shares of BioMarin Pharmaceutical (NASDAQ:BMRN) through any online brokerage.

View our list of the best stock brokerages

Who are BioMarin Pharmaceutical (BMRN) competitors?

Other companies in BioMarin Pharmaceutical’s space includes: BeOne Medicines (NASDAQ:ONC), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).

What is the forecast, or price target, for BioMarin Pharmaceutical (BMRN) stock?

BioMarin Pharmaceutical has a consensus price target of $97.59.

What is the current price for BioMarin Pharmaceutical (BMRN)?

The stock price for BioMarin Pharmaceutical (NASDAQ: BMRN) is $56.22 last updated June 13, 2025 at 4:00 PM EDT.

Does BioMarin Pharmaceutical (BMRN) pay a dividend?

There are no upcoming dividends for BioMarin Pharmaceutical.

When is BioMarin Pharmaceutical (NASDAQ:BMRN) reporting earnings?

BioMarin Pharmaceutical’s Q2 earnings are confirmed for Monday, August 4, 2025.

Is BioMarin Pharmaceutical (BMRN) going to split?

There is no upcoming split for BioMarin Pharmaceutical.

What sector and industry does BioMarin Pharmaceutical (BMRN) operate in?

BioMarin Pharmaceutical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.